GREENLAND MINES LTD Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares
GREENLAND MINES LTD (GRML) had Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares of 298 shares as of 2024-11-06, per its 10-K/A filed 2026-08-14.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares · last filed 2026-08-14
- 2024-11-06: Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares 298.00 shares.
| Period end | Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares |
|---|---|
| 2024-11-06 | 298.00 shares 10-K/A · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |